General Information
Drug ID
DR01262
Drug Name
Actinomycin D
Synonyms
AC1O8OFK; CCG-35952; CCG-36086; NCIMech_000599
Drug Type
Small molecular drug
Indication Ovarian cancer [ICD11: 2C73] Approved [1]
Ewing's sarcoma [ICD11: 2B52] Approved [1]
Testicular cancer [ICD11: 2C80] Approved [1]
Wilms tumor [ICD11: 2C90.Y] Approved [1]
Trophoblastic neoplasm [ICD11: 2C75.0] Approved [1]
Rhabdomyosarcoma [ICD11: 2B55] Approved [1]
Structure
3D MOL 2D MOL
Formula
C62H86N12O16
Canonical SMILES
CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
InChI
InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42+,43+,44-,45-,48-,49-/m1/s1
InChIKey
RJURFGZVJUQBHK-ZXDIMXNISA-N
CAS Number
CAS 50-76-0
Pharmaceutical Properties Molecular Weight 1255.4 Topological Polar Surface Area 356
Heavy Atom Count 90 Rotatable Bond Count 8
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 18
XLogP
3.8
PubChem CID
6713178
PubChem SID
11447246 , 43332629 , 75117941 , 114949108 , 124633807 , 124633941
ChEBI ID
ChEBI:27666
TTD Drug ID
D07ACF
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Actinomycin D was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.